Renaissance Technologies’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Renaissance Technologies’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-17,400	Closed	-$23K	–	3655
2016 Q2	$23K	Buy	+17,400	New	+$27.9K	﹤0.01%	3278
2015 Q2	–	Sell	-16,600	Closed	-$35K	–	3521
2015 Q1	$35K	Sell	16,600 -5,800	-26%	-$13.6K	﹤0.01%	3094
2014 Q4	$30K	Buy	22,400 +12,300	+122%	+$10.7K	﹤0.01%	2906
2014 Q3	$8K	Buy	+10,100	New	+$18.2K	﹤0.01%	2751
2014 Q2	–	Sell	-40,787	Closed	-$122K	–	3121
2014 Q1	$122K	Sell	40,787 -74,500	-65%	-$245K	﹤0.01%	2683
2013 Q4	$362K	Sell	115,287 -8,300	-7%	-$23.2K	﹤0.01%	2452
2013 Q3	$341K	Buy	123,587 +66,980	+118%	+$181K	﹤0.01%	2432
2013 Q2	$141K	Buy	+56,607	New	+$297K	﹤0.01%	2577

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Renaissance Technologies's ECTE Position: Q3 2016 in Review

Renaissance Technologies sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 17,400 shares — an estimated $23K sold.

Renaissance Technologies first reported a position in ECTE in Q2 2013 and held it in 8 quarters. The position peaked at $362K in Q4 2013. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

Renaissance Technologies reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
Renaissance Technologies sold 17,400 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $23K.
Renaissance Technologies first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 8 quarters.
Renaissance Technologies's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $362K in Q4 2013.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.